Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03207763 · ClinicalTrials.gov registry record · NA

Microneedle Patch Study in Healthy Infants/Young Children

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
33
Enrollment target

NCT03207763 is a NA study that has completed, run by Emory University. The registered enrollment target is 33 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03207763, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target

Study Summary

Microneedles can be prepared as a low-cost patch that is simple for patients to apply for vaccine delivery targeting the many antigen-presenting cells present in the skin. Data regarding the safety, reactogenicity, tolerability, and acceptability of a microneedle patch in children are lacking. The goal of this study is to evaluate the safety, reactogenicity, and acceptability of placement of a placebo microneedle patch to the skin of children.

Interventions

  • DEVICE Microneedle Formulation 1
  • DEVICE Microneedle Formulation 2

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2017-07-11
Est. Completion 2019-05-15
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT03207763

The ClinicalTrials.gov registry entry for NCT03207763 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Microneedle Formulation 1 is the first listed.

NCT03207763 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03207763 about?

NCT03207763 is a clinical study titled "Microneedle Patch Study in Healthy Infants/Young Children". Microneedles can be prepared as a low-cost patch that is simple for patients to apply for vaccine delivery targeting the many antigen-presenting cells present in the skin. Data regarding the safety, reactogenicity, tolerability, and acceptability of a microneedle patch in children are lacking. The g...

What is the current status of trial NCT03207763?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2017-07-11. Estimated completion is 2019-05-15.

What interventions are being tested in trial NCT03207763?

The interventions under investigation include: Microneedle Formulation 1 (DEVICE), Microneedle Formulation 2 (DEVICE).

Who is sponsoring clinical trial NCT03207763?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.